Cooperativity and complementarity: Synergies in non-classical and classical glucocorticoid signaling

Cell Cycle

Volumn 11, Issue 15, 2012, Pages 2819-2827

  Samarasinghe, Ranmal A ^a   Witchel, Selma F ^b   DeFranco, Donald B ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

Connexin; Gap junction; Glucocorticoid; Glucocorticoid receptor; Neural progenitor cell

Indexed keywords

CALCIUM; GLUCOCORTICOID; STEROID HORMONE;

CELL PROLIFERATION; CYTOPLASM; GAP JUNCTION; HUMAN; NERVE CELL; NONHUMAN; REVIEW; SIGNAL TRANSDUCTION;

EID: 84864540576     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.21018     Document Type: Review

References (63)

1. Biddie SC, John S, Sabo PJ, Thurman RE, Johnson TA, Schiltz RL, et al. Transcription factor AP1 potentiates chromatin accessibility and glucocorticoid receptor binding. Mol Cell 2011; 43:145-55; PMID:21726817; http://dx.doi.org/10. 1016/j.molcel.2011.06.016.
2. Haller J, Mikics E, Makara GB. The effects of nongenomic glucocorticoid mechanisms on bodily functions and the central neural system. A critical evaluation of findings. Front Neuroendocrinol 2008; 29:273-91; PMID:18054070; http://dx.doi.org/10.1016/j.yfrne.2007.10.004.
3. Pasricha N, Joels M, Karst H. Rapid effects of corticosterone in the mouse dentate gyrus via a non-genomic pathway. J Neuroendocrinol 2010.
4. Qiu J, Wang P, Jing Q, Zhang W, Li X, Zhong Y, et al. Rapid activation of ERK1/2 mitogen-activated protein kinase by corticosterone in PC12 cells. Biochem Biophys Res Commun 2001; 287:1017-24; PMID:11573966; http://dx.doi.org/10.1006/bbrc.2001.5691.
5. Cato AC, Nestl A, Mink S. Rapid actions of steroid receptors in cellular signaling pathways. Sci STKE 2002; 2002:re9; PMID:12084906; http://dx.doi.org/ 10.1126/stke.2002.138.re9.
6. Selye H. Stress and the general adaptation syndrome. Br Med J 1950; 1:1383-92; PMID:15426759; http://dx.doi.org/10.1136/bmj.1.4667.1383.
7. Hammes SR, Levin ER. Extranuclear steroid receptors: nature and actions. Endocr Rev 2007; 28:726-41; PMID:17916740; http://dx.doi.org/10.1210/er.2007- 0022.
8. Pietras RJ, Szego CM. Endometrial cell calcium and oestrogen action. Nature 1975; 253:357-9; PMID:1167402; http://dx.doi.org/10.1038/253357a0.
9. Szego CM, Davis JS. Adenosine 3′,5′-monophosphate in rat uterus: acute elevation by estrogen. Proc Natl Acad Sci USA 1967; 58:1711-8; PMID:4295833; http://dx.doi.org/10.1073/pnas.58.4.1711.
10. McEwen BS. Central effects of stress hormones in health and disease: Understanding the protective and damaging effects of stress and stress mediators. Eur J Pharmacol 2008; 583:174-85; PMID:18282566; http://dx.doi.org/ 10.1016/j.ejphar.2007.11.071.
11. Yeh TF, Lin YJ, Lin HC, Huang CC, Hsieh WS, Lin CH, et al. Outcomes at school age after postnatal dexamethasone therapy for lung disease of prematurity. N Engl J Med 2004; 350:1304-13; PMID:15044641; http://dx.doi.org/ 10.1056/NEJMoa032089.
12. Funder JW. Glucocorticoid and mineralocorticoid receptors: biology and clinical relevance. Annu Rev Med 1997; 48:231-40; PMID:9046958; http://dx.doi.org/10.1146/annurev.med.48.1.231.
13. Sanchez ER. Chaperoning steroidal physiology: Lessons from mouse genetic models of Hsp90 and its cochaperones. Biochim Biophys Acta 2012; 1823:722-9; PMID:22155719; http://dx.doi.org/10.1016/j.bbamcr.2011.11.006.
14. Nagaich AK, Rayasam GV, Martinez ED, Becker M, Qiu Y, Johnson TA, et al. Subnuclear trafficking and gene targeting by steroid receptors. Ann N Y Acad Sci 2004; 1024:213-20; PMID:15265783; http://dx.doi.org/10.1196/annals.1321.002.
15. Pedram A, Razandi M, Levin ER. Nature of functional estrogen receptors at the plasma membrane. Mol Endocrinol 2006; 20:1996-2009; PMID:16645038; http://dx.doi.org/10.1210/me.2005-0525.
16. Acconcia F, Ascenzi P, Bocedi A, Spisni E, Tomasi V, Trentalance A, et al. Palmitoylation-dependent estrogen receptor alpha membrane localization: regulation by 17beta-estradiol. Mol Biol Cell 2005; 16:231-7; PMID:15496458; http://dx.doi.org/10.1091/mbc.E04-07-0547.
17. Groeneweg FL, Karst H, de Kloet ER, Joëls M. Rapid non-genomic effects of corticosteroids and their role in the central stress response. J Endocrinol 2011; 209:153-67; PMID:21357682; http://dx.doi.org/10.1530/JOE-10- 0472.
18. Stavreva DA, Wiench M, John S, Conway-Campbell BL, McKenna MA, Pooley JR, et al. Ultradian hormone stimulation induces glucocorticoid receptormediated pulses of gene transcription. Nat Cell Biol 2009; 11:1093-102; PMID:19684579; http://dx.doi.org/10.1038/ncb1922.
19. Karst H, Berger S, Erdmann G, Schütz G, Joëls M. Metaplasticity of amygdalar responses to the stress hormone corticosterone. Proc Natl Acad Sci USA 2010; 107:14449-54; PMID:20663957; http://dx.doi.org/10.1073/pnas. 0914381107.
20. Solito E, Mulla A, Morris JF, Christian HC, Flower RJ, Buckingham JC. Dexamethasone induces rapid serine-phosphorylation and membrane translocation of annexin 1 in a human folliculostellate cell line via a novel nongenomic mechanism involving the glucocorticoid receptor, protein kinase C, phosphatidylinositol 3-kinase, and mitogen-activated protein kinase. Endocrinology 2003; 144:1164-74; PMID:12639897; http://dx.doi.org/10.1210/en. 2002-220592.
21. Liggins GC, Howie RN. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics 1972; 50:515-25; PMID:4561295.
22. Ballard PL, Ballard RA. Scientific basis and therapeutic regimens for use of antenatal glucocorticoids. Am J Obstet Gynecol 1995; 173:254-62; PMID:7631700; http://dx.doi.org/10.1016/0002-9378(95)90210-4.
23. Newnham JP, Jobe AH. Should we be prescribing repeated courses of antenatal corticosteroids? Semin Fetal Neonatal Med 2009; 14:157-63; PMID:19103515; http://dx.doi.org/10.1016/j.siny.2008.11.005.
24. Sloboda DM, Challis JR, Moss TJ, Newnham JP. Synthetic glucocorticoids: antenatal administration and long-term implications. Curr Pharm Des 2005; 11:1459-72; PMID:15853676; http://dx.doi.org/10.2174/1381612053507873.
25. Karlsson R, Kallio J, Toppari J, Scheinin M, Kero P. Antenatal and early postnatal dexamethasone treatment decreases cortisol secretion in preterm infants. Horm Res 2000; 53:170-6; PMID:11044800; http://dx.doi.org/10.1159/ 000023563.
26. Witchel SF, Azziz R. Congenital adrenal hyperplasia. J Pediatr Adolesc Gynecol 2011; 24:116-26; PMID:21601808; http://dx.doi.org/10.1016/j.jpag.2010. 10.001.
27. David M, Forest MG. Prenatal treatment of congenital adrenal hyperplasia resulting from 21-hydroxylase deficiency. J Pediatr 1984; 105:799-803; PMID:6334149; http://dx.doi.org/10.1016/S0022-3476(84)80310-8.
28. New MI, Carlson A, Obeid J, Marshall I, Cabrera MS, Goseco A, et al. Prenatal diagnosis for congenital adrenal hyperplasia in 532 pregnancies. J Clin Endocrinol Metab 2001; 86:5651-7; PMID:11739415; http://dx.doi.org/10.1210/jc. 86.12.5651.
29. Witchel SF, Miller WL. Prenatal Treatment of Congenital Adrenal Hyperplasia-Not Standard of Care. J Genet Couns 2012; PMID:22639328; http://dx.doi.org/10.1007/s10897-012-9508-8.
30. Meyer-Bahlburg HF, Dolezal C, Baker SW, Carlson AD, Obeid JS, New MI. Cognitive and motor development of children with and without congenital adrenal hyperplasia after early-prenatal dexamethasone. J Clin Endocrinol Metab 2004; 89:610-4; PMID:14764770; http://dx.doi.org/10.1210/jc.2002-021129.
31. Hirvikoski T, Nordenström A, Lindholm T, Lindblad F, Ritzén EM, Wedell A, et al. Cognitive functions in children at risk for congenital adrenal hyperplasia treated prenatally with dexamethasone. J Clin Endocrinol Metab 2007; 92:542-8; PMID:17148562; http://dx.doi.org/10.1210/jc.2006-1340.
32. Hirvikoski T, Nordenström A, Lindholm T, Lindblad F, Ritzén EM, Lajic S. Long-term follow-up of prenatally treated children at risk for congenital adrenal hyperplasia: does dexamethasone cause behavioural problems? Eur J Endocrinol 2008; 159:309-16; PMID:18579553; http://dx.doi.org/10.1530/EJE- 08-0280.
33. Speiser PW, Azziz R, Baskin LS, Ghizzoni L, Hensle TW, Merke DP, et al.; Endocrine Society. Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2010; 95:4133-60; PMID:20823466; http://dx.doi.org/10.1210/jc.2009-2631.
34. Mirescu C, Gould E. Stress and adult neurogenesis. Hippocampus 2006; 16:233-8; PMID:16411244; http://dx.doi.org/10.1002/hipo.20155.
35. McEwen BS. Protection and damage from acute and chronic stress: allostasis and allostatic overload and relevance to the pathophysiology of psychiatric disorders. Ann N Y Acad Sci 2004; 1032:1-7; PMID:15677391; http://dx.doi.org/10.1196/annals.1314.001.
36. Schoenfeld TJ, Gould E. Stress, stress hormones, and adult neurogenesis. Exp Neurol 2012; 233:12-21; PMID:21281629; http://dx.doi.org/10.1016/j. expneurol.2011.01.008.
37. Wong EY, Herbert J. Roles of mineralocorticoid and glucocorticoid receptors in the regulation of progenitor proliferation in the adult hippocampus. Eur J Neurosci 2005; 22:785-92; PMID:16115202; http://dx.doi.org/ 10.1111/j.1460-9568.2005.04277.x.
38. Cheng A, Tang H, Cai J, Zhu M, Zhang X, Rao M, et al. Gap junctional communication is required to maintain mouse cortical neural progenitor cells in a proliferative state. Dev Biol 2004; 272:203-16; PMID:15242801; http://dx.doi.org/10.1016/j.ydbio.2004.04.031.
39. Elias LA, Wang DD, Kriegstein AR. Gap junction adhesion is necessary for radial migration in the neocortex. Nature 2007; 448:901-7; PMID:17713529; http://dx.doi.org/10.1038/nature06063.
40. Samarasinghe RA, Di Maio R, Volonte D, Galbiati F, Lewis M, Romero G, et al. Nongenomic glucocorticoid receptor action regulates gap junction intercellular communication and neural progenitor cell proliferation. Proc Natl Acad Sci USA 2011; 108:16657-62; PMID:21930911; http://dx.doi.org/10.1073/pnas. 1102821108.
41. Weissman TA, Riquelme PA, Ivic L, Flint AC, Kriegstein AR. Calcium waves propagate through radial glial cells and modulate proliferation in the developing neocortex. Neuron 2004; 43:647-61; PMID:15339647; http://dx.doi.org/10.1016/j.neuron.2004.08.015.
42. Bruzzone R, Dermietzel R. Structure and function of gap junctions in the developing brain. Cell Tissue Res 2006; 326:239-48; PMID:16896946; http://dx.doi.org/10.1007/s00441-006-0287-0.
43. Goodenough DA, Paul DL. Beyond the gap: functions of unpaired connexon channels. Nat Rev Mol Cell Biol 2003; 4:285-94; PMID:12671651; http://dx.doi.org/10.1038/nrm1072.
44. Laird DW. Life cycle of connexins in health and disease. Biochem J 2006; 394:527-43; PMID:16492141; http://dx.doi.org/10.1042/BJ20051922.
45. Elias LA, Kriegstein AR. Gap junctions: multifaceted regulators of embryonic cortical development. Trends Neurosci 2008; 31:243-50; PMID:18403031; http://dx.doi.org/10.1016/j.tins.2008.02.007.
46. Nadarajah B, Jones AM, Evans WH, Parnavelas JG. Differential expression of connexins during neocortical development and neuronal circuit formation. J Neurosci 1997; 17:3096-111; PMID:9096144.
47. Bittman K, Becker DL, Cicirata F, Parnavelas JG. Connexin expression in homotypic and heterotypic cell coupling in the developing cerebral cortex. J Comp Neurol 2002; 443:201-12; PMID:11807831; http://dx.doi.org/10.1002/cne.2121.
48. Toyofuku T, Yabuki M, Otsu K, Kuzuya T, Hori M, Tada M. Intercellular calcium signaling via gap junction in connexin-43-transfected cells. J Biol Chem 1998; 273:1519-28; PMID:9430691; http://dx.doi.org/10.1074/jbc.273.3.1519.
49. Huang RP, Hossain MZ, Sehgal A, Boynton AL. Reduced connexin43 expression in high-grade human brain glioma cells. J Surg Oncol 1999; 70:21-4; PMID:9989416; http://dx.doi.org/10.1002/(SICI)1096-9098(199901)70:1〈21:: AIDJSO4〉 3.0.CO;2-0.
50. Tabernero A, Sánchez-Alvarez R, Medina JM. Increased levels of cyclins D1 and D3 after inhibition of gap junctional communication in astrocytes. J Neurochem 2006; 96:973-82; PMID:16412096; http://dx.doi.org/10. 1111/j.1471-4159.2005.03623.x.
51. Warn-Cramer BJ, Cottrell GT, Burt JM, Lau AF. Regulation of connexin-43 gap junctional intercellular communication by mitogen-activated protein kinase. J Biol Chem 1998; 273:9188-96; PMID:9535909; http://dx.doi.org/10.1074/jbc.273. 15.9188.
52. Jasmin JF, Yang M, Iacovitti L, Lisanti MP. Genetic ablation of caveolin-1 increases neural stem cell proliferation in the subventricular zone (SVZ) of the adult mouse brain. Cell Cycle 2009; 8:3978-83; PMID:19923909; http://dx.doi.org/10.4161/cc.8.23.10206.
53. Lin JH, Takano T, Arcuino G, Wang X, Hu F, Darzynkiewicz Z, et al. Purinergic signaling regulates neural progenitor cell expansion and neurogenesis. Dev Biol 2007; 302:356-66; PMID:17188262; http://dx.doi.org/10. 1016/j.ydbio.2006.09.017.
54. Rogatsky I, Trowbridge JM, Garabedian MJ. Glucocorticoid receptor-mediated cell cycle arrest is achieved through distinct cell-specific transcriptional regulatory mechanisms. Mol Cell Biol 1997; 17:3181-93; PMID:9154817.
55. Rogatsky I, Hittelman AB, Pearce D, Garabedian MJ. Distinct glucocorticoid receptor transcriptional regulatory surfaces mediate the cytotoxic and cytostatic effects of glucocorticoids. Mol Cell Biol 1999; 19:5036-49; PMID:10373553.
56. Ross RA, Hein AM, Braca JA 3rd, Spengler BA, Biedler JL, Scammell JG. Glucocorticoids induce neuroendocrine cell differentiation and increase expression of N-myc in N-type human neuroblastoma cells. Oncol Res 2002; 13:87-94; PMID:12392156.
57. Sabolek M, Herborg A, Schwarz J, Storch A. Dexamethasone blocks astroglial differentiation from neural precursor cells. Neuroreport 2006; 17:1719-23; PMID:17047460; http://dx.doi.org/10.1097/01.wnr.0000236862.08834.50.
58. Sundberg M, Savola S, Hienola A, Korhonen L, Lindholm D. Glucocorticoid hormones decrease proliferation of embryonic neural stem cells through ubiquitin-mediated degradation of cyclin D1. J Neurosci 2006; 26:5402-10; PMID:16707792; http://dx.doi.org/10.1523/JNEUROSCI.4906-05.2006.
59. Lodygensky GA, Rademaker K, Zimine S, Gex-Fabry M, Lieftink AF, Lazeyras F, et al. Structural and functional brain development after hydrocortisone treatment for neonatal chronic lung disease. Pediatrics 2005; 116:1-7; PMID:15995023; http://dx.doi.org/10.1542/peds.2004-1275.
60. Benders MJ, Groenendaal F, van Bel F, Ha Vinh R, Dubois J, Lazeyras F, et al. Brain development of the preterm neonate after neonatal hydrocortisone treatment for chronic lung disease. Pediatr Res 2009; 66:555-9; PMID:19851225; http://dx.doi.org/10.1203/PDR.0b013e3181b3aec5.
61. Seckl JR. Prenatal glucocorticoids and long-term programming. Eur J Endocrinol 2004; 151(Suppl 3):U49- 62; PMID:15554887; http://dx.doi.org/10.1530/ eje.0.151U049.
62. Brozanski BS, Jones JG, Gilmour CH, Balsan MJ, Vazquez RL, Israel BA, et al. Effect of pulse dexamethasone therapy on the incidence and severity of chronic lung disease in the very low birth weight infant. J Pediatr 1995; 126:769-76; PMID:7752005; http://dx.doi.org/10.1016/S0022-3476(95)70410-8.
63. Pedram A, Razandi M, Sainson RC, Kim JK, Hughes CC, Levin ER. A conserved mechanism for steroid receptor translocation to the plasma membrane. J Biol Chem 2007; 282:22278-88; PMID:17535799; http://dx.doi.org/10.1074/jbc. M611877200.